Allianz Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$464M Buy
504,764
+77,425
+18% +$78.5M 0.49% 29
2025
Q4
$459M Buy
427,339
+69,610
+19% +$66.6M 0.46% 29
2025
Q3
$273M Sell
357,729
-28,558
-7% -$21.3M 0.3% 54
2025
Q2
$301M Sell
386,287
-61,011
-14% -$47.4M 0.36% 49
2025
Q1
$369M Sell
447,298
-115,987
-21% -$96.5M 0.48% 34
2024
Q4
$435M Sell
563,285
-59,217
-10% -$49M 0.58% 24
2024
Q3
$551M Buy
622,502
+5,940
+1% +$5.34M 0.77% 16
2024
Q2
$558M Buy
616,562
+76,003
+14% +$60.8M 0.83% 16
2024
Q1
$421M Sell
540,559
-31,178
-5% -$22.2M 0.65% 25
2023
Q4
$333M Sell
571,737
-18,936
-3% -$11.1M 0.54% 33
2023
Q3
$317M Buy
590,673
+47,972
+9% +$24.7M 0.53% 38
2023
Q2
$255M Sell
542,701
-7,691
-1% -$3.23M 0.46% 39
2023
Q1
$189M Buy
550,392
+55,660
+11% +$18.8M 0.34% 58
2022
Q4
$181M Sell
494,732
-62,559
-11% -$22.2M 0.35% 60
2022
Q3
$180M Sell
557,291
-1,360,301
-71% -$431M 0.37% 53
2022
Q2
$622M Sell
1,917,592
-342,168
-15% -$103M 0.59% 24
2022
Q1
$647M Sell
2,259,760
-103,505
-4% -$26.6M 0.48% 39
2021
Q4
$653M Sell
2,363,265
-195,109
-8% -$49.5M 0.45% 40
2021
Q3
$591M Buy
2,558,374
+99,182
+4% +$24.5M 0.46% 41
2021
Q2
$564M Buy
2,459,192
+286,725
+13% +$57.6M 0.48% 44
2021
Q1
$406M Buy
2,172,467
+1,084,993
+100% +$212M 0.39% 53
2020
Q4
$184M Buy
1,087,474
+316,313
+41% +$47.2M 0.18% 124
2020
Q3
$114M Sell
771,161
-237,754
-24% -$36.8M 0.13% 169
2020
Q2
$166M Sell
1,008,915
-84,391
-8% -$13M 0.19% 114
2020
Q1
$152M Buy
1,093,306
+19,279
+2% +$2.65M 0.2% 112
2019
Q4
$141M Sell
1,074,027
-259,379
-19% -$30.1M 0.13% 174
2019
Q3
$149M Buy
1,333,406
+66,078
+5% +$7.36M 0.15% 148
2019
Q2
$140M Sell
1,267,328
-11,296
-0.9% -$1.33M 0.13% 171
2019
Q1
$166M Sell
1,278,624
-895,551
-41% -$109M 0.16% 125
2018
Q4
$252M Buy
2,174,175
+60,640
+3% +$6.77M 0.28% 69
2018
Q3
$227M Buy
2,113,535
+317,417
+18% +$31.7M 0.21% 87
2018
Q2
$153M Buy
1,796,118
+651,010
+57% +$53.5M 0.15% 142
2018
Q1
$88.6M Buy
1,145,108
+12,514
+1% +$1.01M 0.08% 260
2017
Q4
$95.7M Buy
1,132,594
+57,909
+5% +$4.93M 0.08% 312
2017
Q3
$91.9M Buy
1,074,685
+65,677
+7% +$5.39M 0.08% 297
2017
Q2
$83.3M Buy
1,009,008
+395,253
+64% +$32.2M 0.08% 293
2017
Q1
$51.6M Sell
613,755
-137,512
-18% -$11M 0.05% 479
2016
Q4
$55.3M Buy
751,267
+267,004
+55% +$19.9M 0.05% 487
2016
Q3
$38.8M Buy
484,263
+52,674
+12% +$4.22M 0.04% 593
2016
Q2
$34M Sell
431,589
-150,854
-26% -$11.4M 0.04% 606
2016
Q1
$41.9M Buy
582,443
+97,828
+20% +$7.4M 0.05% 440
2015
Q4
$41M Sell
484,615
-378,430
-44% -$31.4M 0.05% 466
2015
Q3
$72.2M Sell
863,045
-179,276
-17% -$15.1M 0.09% 244
2015
Q2
$87.1M Sell
1,042,321
-523,387
-33% -$39.9M 0.09% 232
2015
Q1
$114M Sell
1,565,708
-184,590
-11% -$13.1M 0.13% 146
2014
Q4
$121M Buy
1,750,298
+12,256
+0.7% +$827K 0.13% 150
2014
Q3
$113M Sell
1,738,042
-310,763
-15% -$19.7M 0.14% 165
2014
Q2
$127M Sell
2,048,805
-842,921
-29% -$50.3M 0.16% 150
2014
Q1
$170M Buy
2,891,726
+42,550
+1% +$2.37M 0.2% 110
2013
Q4
$145M Buy
2,849,176
+997,500
+54% +$50M 0.19% 127
2013
Q3
$93.2M Buy
1,851,676
+76,324
+4% +$4M 0.12% 217
2013
Q2
$87.2M Buy
+1,775,352
New +$96.6M 0.12% 216

Other funds holding LLY

Allianz Asset Management's LLY Position: Q1 2026 in Review

Allianz Asset Management increased its Eli Lilly (LLY) stake by 18% in Q1 2026, buying an estimated $78.5M and bringing the position to 504,764 shares worth $464M. The position accounts for 0.49% of the portfolio, ranked #29.

Allianz Asset Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $653M in Q4 2021. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Allianz Asset Management held 504,764 shares of Eli Lilly worth $464M as of Q1 2026.
  • Allianz Asset Management bought 77,425 Eli Lilly shares in Q1 2026, an estimated $78.5M.
  • Eli Lilly made up 0.49% of Allianz Asset Management's portfolio in Q1 2026, its #29 holding.
  • Allianz Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Allianz Asset Management's Eli Lilly position peaked at $653M in Q4 2021.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.